Spv2 Pharmaceuticals Llp - Company Profile

It is a business services limited liability partnership based in Lucknow, Uttar Pradesh, India, established in 2019.
2019 Lucknow, Uttar Pradesh, India Struck Off
Last Updated:
Access Report
About Spv2 Pharmaceuticals Llp

Spv2 Pharmaceuticals Llp, a struck off limited liability partnership, was established on 20 September 2019 in Lucknow, Uttar Pradesh, India. Engaging in wholesale within the business services sector, it holds LLPIN: AAQ-6040. Registered under ROC Roc Kanpur. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Jyoti Panday (Designated Partner), Meena Singh (Designated Partner), Renu Agarwal (Designated Partner). Its latest date of accounts and solvency statement 31 March 2020. It is based at Ramdaskhera Manak Nagar Lucknow, Lucknow, Uttar Pradesh, 226016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAQ-6040

  • Incorporation Date

    20 September 2019

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Company Status

    Struck Off

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 6 Year, 5 Months
  • Last Filing with ROC 31 Mar 2020
Company report

Spv2 Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Spv2 Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Spv2 Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Jyoti Panday Designated Partner 20 Sep 2019 Current
Meena Singh Designated Partner 20 Sep 2019 Current
Renu Agarwal Designated Partner 20 Sep 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Spv2 Pharmaceuticals Llp.

Enhance accessibility to Spv2 Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Spv2 Pharmaceuticals Llp revenue growth over time
Spv2 Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Spv2 Pharmaceuticals Llp?

Unlock access to Spv2 Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Spv2 Pharmaceuticals Llp?

Unlock and access historical data on people associated with Spv2 Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Spv2 Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spv2 Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Spv2 Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Spv2 Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2020 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    Spv2 Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Kanpur. was recorded as a recent event.

  • Director Appointment

    The activity Jyoti Panday was appointed as a Designated Partner was appointed as a Designated Partner on 20 Sep 2019 & has been associated with this company since 6 years 5 months . was completed.

  • Director Appointment

    The activity Meena Singh was appointed as a Designated Partner was appointed as a Designated Partner on 20 Sep 2019 & has been associated with this company since 6 years 5 months . was completed.

  • Director Appointment

    Progress on Renu Agarwal was appointed as a Designated Partner was appointed as a Designated Partner on 20 Sep 2019 & has been associated with this company since 6 years 5 months . was documented.

  • LLP Incorporation

    Spv2 Pharmaceuticals Llp was registered on 20 Sep 2019 with Roc Kanpur & aged 6 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Spv2 Pharmaceuticals Llp?

The LLPIN of Spv2 Pharmaceuticals Llp is AAQ-6040.

Where is Spv2 Pharmaceuticals Llp headquartered?

Spv2 Pharmaceuticals Llp is headquartered at Ramdaskhera Manak Nagar Lucknow, Lucknow, Uttar Pradesh, 226016.

When was Spv2 Pharmaceuticals Llp incorporated?

Spv2 Pharmaceuticals Llp was incorporated on 20 September 2019.

Who are the current directors of Spv2 Pharmaceuticals Llp?

The current directors of Spv2 Pharmaceuticals Llp are

What is the primary industry of Spv2 Pharmaceuticals Llp?

The primary industry of Spv2 Pharmaceuticals Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available